Answers are grounded in this paper and cite their sources.
Deregulated nutrient sensing is a hallmark of aging, but endocrine and anabolic signals remain essential for glucose homeostasis, tissue repair, and preservation of muscle and bone. We propose Metabo Quit as a testable dietary framework for reducing persistent nutrient-responsive growth signaling when it exceeds physiological need, without inducing endocrine deficiency or chronic catabolism. Insulin and insulin-like growth factor 1 (IGF-1) are treated as representative sentinel signals within a wider network that includes amino-acid sensing, mTOR-S6K, PKA, AMPK, FOXO, incretin, and autophagy pathways. D-allulose is positioned as a candidate nutritional probe because controlled human studies support modest attenuation of postprandial glycemia and, in some settings, insulin responses. Importantly, D-allulose extended lifespan in Caenorhabditis elegans under monoxenic and axenic culture conditions; non-additivity in the dietary-restriction model eat-2 and loss of the effect in aak-2 mutants support an aak-2 -dependent, dietary-restriction-like mechanism. This organism-level finding strengthens biological plausibility, but evidence that D-allulose slows biological aging or extends healthspan in mammals or humans is not available. The framework is conceptually aligned with fasting and fasting-mimicking diets while addressing a distinct question: whether an ordinary food substitution can reduce repeated metabolic stimulation without reproducing fasting. We outline matched-meal studies, mechanistic readouts, safety safeguards, and falsification criteria. This Perspective reframes D-allulose beyond sweetening as a tool for testing whether the temporal burden of nutrient-responsive signaling can be moderated in support of healthy aging.
No takes yet. Share an insight, caveat, or question.
Fukunaga et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: